News
Important Only
Boltz And Pfizer Announce Strategic Collaboration To Develop And Deploy Biomolecular Ai Foundation Models
Jan 8 (Reuters) - Pfizer Inc PFE.N:BOLTZ AND PFIZER ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND DEPLOY STATE-OF-THE-ART BIOMOLECULAR AI FOUNDATION MODELSPFIZER - BOLTZ AND PFIZER ANNOUNCE STRATEGIC COLLABORATION FOR AI MODELSPFIZER: WILL RETAIN FULL OWNERSHIP OF ALL COMPOUNDS DISCOVERED OR DEVEL...Reuters
Thu, Jan 8
Lynn Stockwell And Bright Green Corporation File $3 Billion Lawsuit Against Rodey Law Firm and ALAS
Jan 8 (Reuters) - Bright Green Corp BGXXQ.PK:LYNN STOCKWELL AND BRIGHT GREEN CORPORATION FILE $3 BILLION LAWSUIT AGAINST RODEY LAW FIRM AND ATTORNEYS’ LIABILITY ASSURANCE SOCIETY (ALAS) FOR LEGAL MALPRACTICE AND BAD FAITHBRIGHT GREEN CORP: COURT FOUND NO WRONGDOING BY LYNN STOCKWELL; JUDGMENT IMPOSE...Reuters
Thu, Jan 8
Deals of the day-Mergers and acquisitions
Jan 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Thursday: Paramount Skydance reaffirmed its $30-per-share cash bid for Warner Bros Discovery , reiterating that its offer is superior to the HBO Max owner's deal...Reuters
Thu, Jan 8
Air Canada Intends To Extend And Expand Commercial Agreement With Pal Airlines
Jan 8 (Reuters) - Air Canada AC.TO:AIR CANADA INTENDS TO EXTEND AND EXPAND COMMERCIAL AGREEMENT WITH PAL AIRLINESAIR CANADA - AGREEMENT TO BE EXTENDED BY FOUR YEARS TO 2032AIR CANADA - PAL AIRLINES AIRCRAFT COVERED BY AGREEMENT TO INCREASE TO ELEVENReuters
Thu, Jan 8
Astronics Corporation Announces Preliminary Unaudited Revenue For Fourth Quarter 2025
Jan 8 (Reuters) - Astronics Corp ATRO.O:ORATION ANNOUNCES PRELIMINARY UNAUDITED REVENUE FOR FOURTH QUARTER 2025 AND INITIATES REVENUE GUIDANCE FOR 2026REPORTS Q4 REVENUE OF $236-$239 MILLION2026 REVENUE GUIDANCE $950-$990 MILLIONFY2026 REVENUE VIEW $951.3 MILLION -- LSEG IBES DATAQ4 REVENUE VIEW $23...Reuters
Thu, Jan 8
Volaris Reports December 2025 Traffic Results Load Factor Of 84%
Jan 8 (Reuters) - Controladora Vuela Compania de Aviacion SAB de CV VOLARA.MX:VOLARIS REPORTS DECEMBER 2025 TRAFFIC RESULTS: LOAD FACTOR OF 84%CONTROLADORA VUELA COMPANIA DE AVIACION SAB DE CV - IN DECEMBER 2025, ASM CAPACITY INCREASED 9.5%Reuters
Thu, Jan 8
Oncolytics Biotech® Provides Update On Intellectual Property Strategy And Patent Filings
Jan 8 (Reuters) - Oncolytics Biotech Inc ONCY.O:ONCOLYTICS BIOTECH® PROVIDES UPDATE ON INTELLECTUAL PROPERTY STRATEGY AND PATENT FILINGSONCOLYTICS BIOTECH INC - PLANS ADDITIONAL PATENT APPLICATIONS FOR PELAREOREPONCOLYTICS BIOTECH INC - TO PURSUE ADDITIONAL IP OPPORTUNITIES IN 2026Reuters
Thu, Jan 8
